Factors Affecting First-Line Triple Therapy of Helicobacter pylori Including CYP2C19 Genotype and Antibiotic Resistance

被引:0
|
作者
Ju Yup Lee
Nayoung Kim
Min Soo Kim
Yoon Jin Choi
Jung Won Lee
Hyuk Yoon
Cheol Min Shin
Young Soo Park
Dong Ho Lee
Hyun Chae Jung
机构
[1] Seoul National University Bundang Hospital,Department of Internal Medicine
[2] Seoul National University College of Medicine,Department of Internal Medicine and Liver Research Institute
来源
Digestive Diseases and Sciences | 2014年 / 59卷
关键词
Clarithromycin; Treatment failure; Drug resistance;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1235 / 1243
页数:8
相关论文
共 50 条
  • [1] Factors Affecting First-Line Triple Therapy of Helicobacter pylori Including CYP2C19 Genotype and Antibiotic Resistance
    Lee, Ju Yup
    Kim, Nayoung
    Kim, Min Soo
    Choi, Yoon Jin
    Lee, Jung Won
    Yoon, Hyuk
    Shin, Cheol Min
    Park, Young Soo
    Lee, Dong Ho
    Jung, Hyun Chae
    DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (06) : 1235 - 1243
  • [2] First-line eradication for Helicobacter pylori-positive gastritis by esomeprazole-based triple therapy is influenced by CYP2C19 genotype
    Saito, Yoshimasa
    Serizawa, Hiroshi
    Kato, Yukako
    Nakano, Masaru
    Nakamura, Masahiko
    Saito, Hidetsugu
    Suzuki, Hidekazu
    Kanai, Takanori
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (48) : 13548 - 13554
  • [3] Efficacy of tailored Helicobacter pylori eradication therapy based on antibiotic susceptibility and CYP2C19 genotype
    Mitsushige Sugimoto
    Takahisa Furuta
    World Journal of Gastroenterology, 2014, (21) : 6400 - 6411
  • [4] Efficacy of tailored Helicobacter pylori eradication therapy based on antibiotic susceptibility and CYP2C19 genotype
    Sugimoto, Mitsushige
    Furuta, Takahisa
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (21) : 6400 - 6411
  • [5] Helicobacter pylori erradication and its relation to antibiotic resistance and CYP2C19 status
    Garza Gonzalez, E.
    Giasi Gonzalez, E.
    Martinez Vazquez, M. A.
    Perez Perez, G. I.
    Gonzalez, G. M.
    Maldonado Garza, H. J.
    Bosques Padilla, E. J.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2007, 99 (02) : 71 - 75
  • [6] Effect of Antibiotic Susceptibility and CYP3A4/5 and CYP2C19 Genotype on the Outcome of Vonoprazan-Containing Helicobacter pylori Eradication Therapy
    Sugimoto, Mitsushige
    Hira, Daiki
    Murata, Masaki
    Kawai, Takashi
    Terada, Tomohiro
    ANTIBIOTICS-BASEL, 2020, 9 (10): : 1 - 11
  • [7] Efficacy and Tolerability of First-Line Triple Therapy With Levofloxacin and Amoxicillin Plus Esomeprazole or Rabeprazole for the Eradication of Helicobacter pylori Infection and the Effect of CYP2C19 Genotype: A 1-Week, Randomized, Open-Label Study in Chinese Adults
    Pan, Xiaolin
    Li, Yuqing
    Qiu, Yuping
    Tang, Qiyun
    Qian, Bingbing
    Yao, Linhua
    Shi, Ruihua
    Zhang, Guoxin
    CLINICAL THERAPEUTICS, 2010, 32 (12) : 2003 - 2011
  • [8] Trends in Helicobacter pylori eradication rates by first-line triple therapy and related factors in eradication therapy
    Kim, Sung Eun
    Park, Moo In
    Park, Seun Ja
    Moon, Won
    Choi, Youn Jung
    Cheon, Ji Hyun
    Kwon, Hye Jung
    Ku, Ki Hwan
    Yoo, Chang Hun
    Kim, Jae Hyun
    Lee, Gyu Won
    Song, Sung Eun
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2015, 30 (06) : 801 - 807
  • [9] Hybrid Therapy as First-Line Regimen for Helicobacter pylori Eradication in Populations with High Antibiotic Resistance Rates
    Song, Zhiqiang
    Zhou, Liya
    Zhang, Jianzhong
    He, Lihua
    Bai, Peng
    Xue, Yan
    HELICOBACTER, 2016, 21 (05) : 382 - 388
  • [10] Influence of CYP2C19 functional polymorphism on Helicobacter pylori eradication
    Ozdil, Burhan
    Akkiz, Hikmet
    Bayram, Suleyman
    Bekar, Aynur
    Akgollu, Ersin
    Sandikci, Macit
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2010, 21 (01) : 23 - 28